UWKI yields 200000000.00% · PFE yields 6.13%● Live data
📍 UWKI pulled ahead of the other in Year 1
Combined, UWKI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UWKI + PFE for your $10,000?
uWink Inc. Del develops and operates digital media entertainment and hospitality software. It also develops and operates an interactive restaurant concept under the name uWink that incorporates and showcases its entertainment and hospitality software. It offers Hospitality ordering, a touch-based user interface that allows users to self-order various food and drink through touch screen terminals; Self check in/checkout software, which enables users to self-check in and checkout at the table using a credit card or pre-paid debit card; and Multi-player game platform, which allows users to play digital games in real time. The company also provides uWink Game Library that features single and multi-player short-form, casual, and social video games; Micro-transaction game play monetization software for game credit purchasing, tracking, and redemption; Media display system, which exhibits revolving imagery for restaurants to change its look and feel. In addition, it licenses SNAP!, a countertop video game platform; and Bear Shop, an entertainment vending platform to third party manufacturers. Its restaurant menu features a selection of appetizers, entrees, pizzas, burgers, salads, pastas, and desserts. The company was incorporated in 1999 and is based in Van Nuys, California.
Full UWKI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.